Check out this article in @ozm by @emilylmullin featuring our CSO, @LauraSeppLore, discussing Intellia’s approach for a potential in vivo #sicklecelldisease treatment, which may help overcome challenges with access to treatment in developing countries. https://t.co/DdxSlBAYll